Single-Cell Dissection of Immune Cells in High-risk Smoldering Multiple Myeloma
Patients with Smoldering Multiple Myeloma (SMM) are currently followed until clinical progression to Multiple Myeloma (MM). Two randomized Phase III...
Volume 2, Issue 2
Research Spotlight
Meet the Expert: Smoldering Myeloma
One of the ‘Meet the Professor’ sessions at the 19th International Myeloma Society Annual Meeting was focused on Smoldering Multiple...
Epigenomic Regulation
A highlight of three recent studies focused on the evaluation of epigenomic alterations in myeloma cells, which may lead to...
Targeting the Undruggable in Multiple Myeloma
Cell identity is controlled by the action of a small number of master transcription factors (TFs) that recognize and bind...
Turning Cold into Hot Myeloma
Anticancer drugs mediate their activity not only by direct cytostatic or cytotoxic effects but also stressing cancer cells in such...